Search

everythinglearnresearchcommunity

for

Search:↓

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Serenoa repens, a natural compound, can increase hair count and help repair capillaries, making it a promising treatment for hair loss.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Hydroxychloroquine may help delay skin damage in lupus patients.

Vitamin D is important for skin health and can help treat psoriasis, atopic dermatitis, and vitiligo.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Testosterone's effects on COVID-19 are unclear and need more research.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

About 11% of patients with secondary syphilis had Syphilitic Alopecia, which usually improved with treatment.

Certain nail conditions can suggest thyroid problems, with different symptoms for underactive (slow, thin nails) and overactive (spoon-shaped, brittle nails) thyroid.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.